Bioequivalence assessment of pharmaceutical aerosol products through IVIVC.
Sign Up to like & getrecommendations! Published in 2021 at "Advanced drug delivery reviews"
DOI: 10.1016/j.addr.2021.113895
Abstract: Many pharmaceutical developers of generic orally inhaled products (OIPs) are facing significant issues in passing the regulatory requirement to show pharmacokinetic (PK) bioequivalence (BE) to the originator product. The core of the issue is that… read more here.
Keywords: bioequivalence; products ivivc; aerosol products; assessment pharmaceutical ... See more keywords